PMC:7405836 / 111143-111477 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T27 263-269 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T984 124-132 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T985 212-220 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T986 212-216 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T78 174-177 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T79 223-231 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T80 263-269 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T185 64-74 Chemical denotes ivermectin http://purl.obolibrary.org/obo/CHEBI_6078

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T758 0-334 Sentence denotes Based on the pharmacokinetic simulation, it was also found that ivermectin may have limited therapeutic utility in managing COVID-19, since the inhibitory concentration that has to be achieved for effective anti-SARS-CoV-2 activity is far higher than the maximum plasma concentration achieved by administering the approved dose (340).

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3036 212-222 Species denotes SARS-CoV-2 Tax:2697049
3043 124-132 Disease denotes COVID-19 MESH:C000657245